POC(Point of Care) 진단 시장 : 예측(2025-2030년)

The point of care diagnostic market is expected to grow from USD 36.725 billion in 2025 to USD 49.209 billion in 2030, at a CAGR of 6.03%.

The point-of-care (POC) diagnostics market, encompassing bedside testing performed outside traditional laboratory settings, has seen significant growth driven by technological advancements and rising healthcare needs. POC testing enables rapid evaluation, diagnosis, prognosis, and screening, reducing errors and improving efficiency. The availability of portable, handheld, and transportable devices has expanded testing capabilities beyond hospitals to homes, emergency care, and convenience clinics, meeting the growing demand for accessible diagnostics.

Market Drivers

The increasing prevalence of chronic and infectious diseases is a primary driver of the POC diagnostics market. In emerging nations like China and India, the rising incidence of cardiovascular diseases and diabetes has heightened demand. For instance, the International Diabetes Federation reported in 2021 that 537 million adults aged 20-79 globally were living with diabetes, with significant numbers in these countries. Similarly, infectious diseases such as HIV and tuberculosis (TB) are fueling market growth. UNAIDS estimated 20.6 million people were living with HIV in 2019, including 2.1 million in India, driving demand for POC diagnostics to accelerate treatment. The World Health Organization noted India's high TB burden, with 2.64 million cases in 2020, further emphasizing the need for rapid diagnostics in resource-limited settings. Additionally, respiratory syncytial virus (RSV) affects four to five million children annually worldwide, contributing to the demand for POC testing to manage such disorders effectively.

Geographical Outlook

North America is poised for significant growth in the POC diagnostics market during the forecast period. The surge in COVID-19 cases has been a key factor, increasing the need for rapid testing solutions. The region benefits from robust product innovation, a rising incidence of infectious and chronic diseases, and supportive governmental initiatives promoting early detection and regular health check-ups. The United States and Canada are pivotal markets, driven by increased healthcare expenditure, a growing number of hospitals and diagnostic laboratories, and strategic collaborations among industry players. These factors collectively enhance the adoption of POC devices, positioning North America as a leader in market expansion.

The POC diagnostics market is expanding rapidly due to the rising prevalence of chronic and infectious diseases, technological advancements in portable devices, and supportive healthcare policies, particularly in North America. The market's growth is further propelled by the need for rapid, accessible diagnostics in diverse settings, addressing critical healthcare challenges in both developed and emerging regions.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries

Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Point of Care Diagnostics Market Segmentation

By Testing

• Cardio-Metabolic Monitoring Kits
• Infectious Disease Testing Kits
• Glucose Monitoring Kits
• Coagulation Monitoring Kits
• Tumor/Cancer Markers
• Pregnancy & Fertility Testing
• Urinalysis Testing Kit
• Hematology Testing
• Others

By Platform

• Lateral Flow Assay
• Dipstick
• MicroFluids
• Molecular Diagnostics
• Others

By Mode

• Prescription
• Over-the-counter (OTC)

By End-User

• Hospitals
• Diagnostics Centers
• Others

By Geography

• North America
• USA
• Canada
• Others
• South America
• Brazil
• Others
• Europe
• Germany
• UK
• France
• Spain
• Others
• Middle East and Africa
• Israel
• Others
• Asia Pacific
• China
• Japan
• South Korea
• India
• Thailand
• Indonesia
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. POINT OF CARE DIAGNOSTICS MARKET BY TESTING

• 5.1. Introduction
• 5.2. Cardio-Metabolic Monitoring Kits
• 5.3. Infecious Disease Testing Kits
• 5.4. Glucose Monitoring Kits
• 5.5. Coagulation Monitoring Kits
• 5.6. Tumor/Cancer Marker
• 5.7. Pregnancy & Fertility Testing
• 5.8. Urinalysis Testing Kit
• 5.9. Hematology Testing
• 5.10. Others

6. POINT OF CARE DIAGNOSTICS MARKET BY PLATFORM

• 6.1. Introduction
• 6.2. Lateral Flow Assay
• 6.3. Dipsticks
• 6.4. Microfluids
• 6.5. Molecular Diagnostics
• 6.6. Others

7. POINT OF CARE DIAGNOSTICS MARKET BY MODE

• 7.1. Introduction
• 7.2. Prescription
• 7.3. Over-The-Counter (OTC)

8. POINT OF CARE DIAGNOSTICS MARKET BY END-USER

• 8.1. Introduction
• 8.2. Hospitals
• 8.3. Diagnostics Centers
• 8.4. Others

9. POINT OF CARE DIAGNOSTICS MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. USA
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. Germany
  • 9.4.2. France
  • 9.4.3. United Kingdom
  • 9.4.4. Spain
  • 9.4.5. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. India
  • 9.6.3. Japan
  • 9.6.4. South Korea
  • 9.6.5. Indonesia
  • 9.6.6. Thailand
  • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Abbott Laboratories
• 11.2. Becton, Dickinson and Company
• 11.3. Biosynex
• 11.4. Danaher Corporation
• 11.5. EKF Diagnostics
• 11.6. Nova Biomedical
• 11.7. Quidel Corporation
• 11.8. Siemens AG
• 11.9. Trinity Biotech
• 11.10. WerfenLife S.A

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key benefits for the stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations